ADVANCED ESOPHAGEAL ADENOCARCINOMA
Clinical trials for ADVANCED ESOPHAGEAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ESOPHAGEAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED ESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug targets common cancer driver in first human trial
Disease control Recruiting nowThis is an early-stage study testing a new drug called BGB-53038, which is designed to block a specific protein (KRAS) that drives the growth of many advanced solid tumors. The main goal is to find a safe dose and see how the body handles the drug, both when given alone and when …
Matched conditions: ADVANCED ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Major cancer trial tests if adding one drug helps patients live longer
Disease control Recruiting nowThis large, late-stage trial is testing which of two chemotherapy combinations works better for people with advanced stomach or esophageal cancer that has spread and cannot be removed by surgery. About 382 participants will be randomly assigned to receive either the standard two-…
Matched conditions: ADVANCED ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for Tough-to-Treat cancers: adding immune booster to standard care
Disease control Recruiting nowThis study is for people with advanced stomach or esophageal cancer that has worsened after initial treatment. It tests if adding an immunotherapy drug called nivolumab to the standard two-drug chemotherapy helps control the cancer better and helps patients live longer. About 224…
Matched conditions: ADVANCED ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New drug combo trial aims to shrink tough stomach cancers
Disease control Recruiting nowThis study is testing whether adding a new drug called ivonescimab to standard chemotherapy helps shrink tumors better in people with advanced stomach or esophageal cancer. It will enroll 88 adults whose cancer has spread or cannot be removed by surgery. The main goal is to see i…
Matched conditions: ADVANCED ESOPHAGEAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC